Welcome to ELISHA.
 

This is the Technical Web Site of ELISHA Systems Ltd.


ELISHA was the acronym of the EU project funded under the Nanotechnology Theme of Framework 6.  The project was completed on 30th June 2007 and the technology is being commercialised by ELISHA Systems Ltd., a new SME based in the UK.

 

Main Contacts for ELISHA Systems Ltd:


Technical Enquiries

Dr Tim Gibson           Telephone 0113 246 9749 

                                  e-mail  timdgibson@merchab.fsnet.co.uk

 

Business Enquiries

Dr Graham Johnson   Telephone 01298 70891

                                  e-mail  graham.johnson@uniscan.com

 

Registered Address

Sigma House, Burlow Road, Buxton, Derbyshire, SK17 9JB, UK
Company number  6142403

The full title of the project was:

Electro-Immunointerfaces and Surface Nanobiotechnology: A Heterodoxical Approach.


The project was based around the use of antibodies for diagnostics, with the aim of producing simple biosensors based on affinity reactions but with no labels.


Previously, affinity biosensors based on antibodies, usually called 'immunosensors' have had a major disadvantage in that they need extra reagents to report the antibody-antigen affinity reaction.  Reporters can be enzymes, fluorescent molecules or radioactive isotopes.

 

To improve immunosensors, the ELISHA project has developed electrochemical biosensors based on antibodies that report antibody-antigen affinity reactions with no added labels. Also simple instrumentation enabling immunosensing to be available to unskilled personnel has been designed.

 

The initial target analytes were fluoroquinoline antibiotics, cancer markers such as PSA and prion peptides.  During the project the ELISHA methodology has been applied to 15 different analytes and appears to be applicable to virtually any antibody - antigen couple. Furthermore other types of affinity reactions, such as receptors and binding proteins have been demonstrated to give electrochemical signals.  The ELISHA technology is a true 'platform' technology and is being commercialised through a new SME, ELISHA Systems Ltd (ESL). Contact Dr Tim Gibson or Dr Graham Johnson for details using the registration form on the 'Register Interest' page above.


Latest News

08/Jun/2010

ELISHA Systems Ltd at the Biosensors World Congress in Glasgow, May 2010

Dr Tim Gibson presented a poster at the Biosensors World Congress in Glasgow, Scotland in May 2010. A pdf of the poster is available here.

...read more


29/Mar/2010

Sensitive Detection of Bacteria

Using bacteria specific antibodies in the ELISHA platform, C difficile, MRSA and MSSA have been detected in under 30 minutes, indicationg the causitive organisms of HAI's could be measured and identified rapidly.

...read more


14/Oct/2009

1st Biosensing Technology Conference, Bristol, UK 10th to 12th November 2009

Dr Tim Gibson will be at the 1st Biosensing Technology Conference to be held in Bristol, UK in November 2009.

...read more